|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011306,
umls-concept:C0023395,
umls-concept:C0026473,
umls-concept:C0030705,
umls-concept:C0045093,
umls-concept:C0178602,
umls-concept:C0205179,
umls-concept:C0205263,
umls-concept:C0205272,
umls-concept:C0346647,
umls-concept:C0442805,
umls-concept:C1334145,
umls-concept:C1367477
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2009-11-27
|
|
pubmed:abstractText |
Chemotherapy and immunotherapy often seem to contradict each other. However, recent reports suggested that the anticancer effects in some chemotherapeutic agents were concerned with immune response. This study was designed to evaluate the immunological reaction by gemcitabine for future clinical trial of combination therapy with gemcitabine and cancer vaccines.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1465-3621
|
|
pubmed:author |
pubmed-author:HeikeYujiY,
pubmed-author:HyodoIchinosukeI,
pubmed-author:IkedaMasafumiM,
pubmed-author:MakiyamaHiroakiH,
pubmed-author:Morita-HoshiYurikoY,
pubmed-author:MorizaneChigusaC,
pubmed-author:OkusakaTakujiT,
pubmed-author:SoedaAtsukoA,
pubmed-author:TakahashiNorikoN,
pubmed-author:TakaueYoichiY,
pubmed-author:UenoHidekiH,
pubmed-author:YamagataShizukaS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
797-806
|
|
pubmed:meshHeading |
pubmed-meshheading:19797418-Adult,
pubmed-meshheading:19797418-Aged,
pubmed-meshheading:19797418-Aged, 80 and over,
pubmed-meshheading:19797418-Antigens, CD11c,
pubmed-meshheading:19797418-Antigens, CD14,
pubmed-meshheading:19797418-CD8-Positive T-Lymphocytes,
pubmed-meshheading:19797418-Cancer Vaccines,
pubmed-meshheading:19797418-Combined Modality Therapy,
pubmed-meshheading:19797418-Dendritic Cells,
pubmed-meshheading:19797418-Deoxycytidine,
pubmed-meshheading:19797418-Female,
pubmed-meshheading:19797418-Humans,
pubmed-meshheading:19797418-Immunotherapy,
pubmed-meshheading:19797418-Interferon-gamma,
pubmed-meshheading:19797418-Interleukin-4,
pubmed-meshheading:19797418-Killer Cells, Natural,
pubmed-meshheading:19797418-Lymphocyte Activation,
pubmed-meshheading:19797418-Male,
pubmed-meshheading:19797418-Middle Aged,
pubmed-meshheading:19797418-Monocytes,
pubmed-meshheading:19797418-Pancreatic Neoplasms
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Regular dose of gemcitabine induces an increase in CD14+ monocytes and CD11c+ dendritic cells in patients with advanced pancreatic cancer.
|
|
pubmed:affiliation |
Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
